Experimental treatment for recurrent brain cancer offers new hope

At Lenox Hill Hospital, a new clinical trial led by John Boockvar, MD, offers hope for those suffering from recurrent brain cancer, glioblastoma multiforme -- the study involving an experimental treatment of delivering high doses of chemotherapy drug, Cetuximab, directly to the tumor site through the artery, instead of the vein, shrinks tumor in patient from Long Island.

Get the latest health news

Keep up-to-date on breaking health news with insights from our experts and developments from around the health system.